These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 22272823)

  • 1. A concise review of current radiopharmaceuticals in tumor angiogenesis imaging.
    Lu X; Wang RF
    Curr Pharm Des; 2012; 18(8):1032-40. PubMed ID: 22272823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiolabeled multimeric cyclic RGD peptides as integrin alphavbeta3 targeted radiotracers for tumor imaging.
    Liu S
    Mol Pharm; 2006; 3(5):472-87. PubMed ID: 17009846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imaging of Integrin α
    Song YS; Park HS; Lee BC; Jung JH; Lee HY; Kim SE
    Cancer Biother Radiopharm; 2017 Oct; 32(8):288-296. PubMed ID: 29053416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pegylated Arg-Gly-Asp peptide: 64Cu labeling and PET imaging of brain tumor alphavbeta3-integrin expression.
    Chen X; Hou Y; Tohme M; Park R; Khankaldyyan V; Gonzales-Gomez I; Bading JR; Laug WE; Conti PS
    J Nucl Med; 2004 Oct; 45(10):1776-83. PubMed ID: 15471848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiolabeled RGD peptides as integrin alpha(v)beta3-targeted PET tracers.
    Tateishi U; Oka T; Inoue T
    Curr Med Chem; 2012; 19(20):3301-9. PubMed ID: 22664242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ligands for mapping alphavbeta3-integrin expression in vivo.
    Schottelius M; Laufer B; Kessler H; Wester HJ
    Acc Chem Res; 2009 Jul; 42(7):969-80. PubMed ID: 19489579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular Imaging of Breast Cancer: Role of RGD Peptides.
    Chakravarty R; Chakraborty S; Dash A
    Mini Rev Med Chem; 2015; 15(13):1073-94. PubMed ID: 26349490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imaging integrin αvβ3 on blood vessels with 111In-RGD2 in head and neck tumor xenografts.
    Terry SY; Abiraj K; Frielink C; van Dijk LK; Bussink J; Oyen WJ; Boerman OC
    J Nucl Med; 2014 Feb; 55(2):281-6. PubMed ID: 24408894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of RGD-based radiotracers for tumor imaging and therapy: translating from bench to bedside.
    Liu Z; Wang F
    Curr Mol Med; 2013 Dec; 13(10):1487-505. PubMed ID: 24206140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multimodality Imaging in Tumor Angiogenesis: Present Status and Perspectives.
    Niccoli Asabella A; Di Palo A; Altini C; Ferrari C; Rubini G
    Int J Mol Sci; 2017 Aug; 18(9):. PubMed ID: 28846661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multimodality molecular imaging of tumor angiogenesis.
    Cai W; Chen X
    J Nucl Med; 2008 Jun; 49 Suppl 2():113S-28S. PubMed ID: 18523069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PET-Based Human Dosimetry of the Dimeric αvβ3 Integrin Ligand 68Ga-DOTA-E-[c(RGDfK)]2, a Potential Tracer for Imaging Tumor Angiogenesis.
    López-Rodríguez V; Galindo-Sarco C; García-Pérez FO; Ferro-Flores G; Arrieta O; Ávila-Rodríguez MA
    J Nucl Med; 2016 Mar; 57(3):404-9. PubMed ID: 26585063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A review: Integrin alphavbeta3-targeted molecular imaging and therapy in angiogenesis.
    Lim EH; Danthi N; Bednarski M; Li KC
    Nanomedicine; 2005 Jun; 1(2):110-4. PubMed ID: 17292065
    [No Abstract]   [Full Text] [Related]  

  • 14. RGD mimetics γ-AApeptides and methods of use (US 20,140,004,039 A1): a patent evaluation.
    Wu H; Jiang J; Xu H; Li Q; Cai J
    Expert Opin Ther Pat; 2016; 26(1):131-7. PubMed ID: 26560186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular imaging of αvß3 expression in cancer patients.
    Gaertner FC; Schwaiger M; Beer AJ
    Q J Nucl Med Mol Imaging; 2010 Jun; 54(3):309-26. PubMed ID: 20639816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of (68)Ga-labeled NOTA-RGD-GE11 heterodimeric peptide for dual integrin and epidermal growth factor receptor-targeted tumor imaging.
    Yu HM; Chen JH; Lin KL; Lin WJ
    J Labelled Comp Radiopharm; 2015 Jun; 58(7):299-303. PubMed ID: 25997858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Application of Radiolabeled RGD Peptides for PET Imaging of Integrin αvβ3.
    Chen H; Niu G; Wu H; Chen X
    Theranostics; 2016; 6(1):78-92. PubMed ID: 26722375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted in vivo imaging of angiogenesis: present status and perspectives.
    Choe YS; Lee KH
    Curr Pharm Des; 2007; 13(1):17-31. PubMed ID: 17266586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiogenesis Imaging Using (68)Ga-RGD PET/CT: Therapeutic Implications.
    Eo JS; Jeong JM
    Semin Nucl Med; 2016 Sep; 46(5):419-27. PubMed ID: 27553467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular Imaging of Angiogenesis in Oncology: Current Preclinical and Clinical Status.
    Florea A; Mottaghy FM; Bauwens M
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34073992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.